A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma

Annals of Hematology

Volumn 79, Issue 7, 2000, Pages 396-401

  Nakamura, H ^a   Inokuchi, K ^a   Hanawa, H ^a   Yamaguchi, H ^a   Tamura, H ^a   Tajika, K ^a   Dan, K ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

CML; Fluorouracil; Minor bcr abl; Therapy related leukemia

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; DOXORUBICIN; FLUOROURACIL;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; ESOPHAGUS CARCINOMA; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033912037     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002779900151     Document Type: Article

References (40)

1. Aguiar RCT, Sill H, Hochhaus A, Goldman JM, Cross NC (1996) Molecular investigation of secondary chronic myeloid leukemia. Blood 88:2808-2809
2. Carella AM, Lerma E, Corsetti MT, Dejana A, Celesti L, Casarino L, De Stefano F, Frassoni F (1998) Evidence of cytogenetic and molecular remission by allogeneic cells after immunosuppressive therapy alone. Br J Haematol 103:565-567
3. Costello RT, Gabert J, Brunel V, Sainty D, Arnoulet C, Mozziconacci MJ, Camerlo J, Perret C, Gastaut JA, Bouabdallah R, Lafage-Pochitalhoff M (1995) Minor breakpoint cluster region (m-BCR) positive chronic myeloid leukaemia with an acute lymphoblastic leukaemia onset: a case report. Br J Haematol 91:428-430
4. Diamandidou E, Buzdar AU, Smith TL, Frye D, Witjaksono M, Hortobagyi GN (1996) Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience. J Clin Oncol 14:2722-2730
5. Greene MH, Boice JD Jr, Greer BE, Blessing JA, Dembo AJ (1982) Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials. N Engl J Med 307:1416-1421
6. Grunwald HW, Rosner F (1979) Acute leukemia and immunosuppressive drug use: a review of patients undergoing immunosuppressive therapy for non-neoplastic diseases. Arch Intern Med 139:461-466
7. Guo JQ, Hirsch-Ginsberg CF, Xian YM, Stass SA, Champlin RE, Giralt SA, McCredie KB, Campbell ML, Arlinghaus RB (1993) Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia. Hematol Pathol 7:91-106
8. Haferlach T, Winkemann M, Nickenig C, Meeder M, Ramm-Petersen L, Schoch R, Nickelsen M, Weber-Matthiesen K, Schlegelberger B, Schoch C, Gassmann W, Loffier H (1997) Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grunwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol 97:99-106
9. Haq AU (1990) Transformation of polycythemia vera to Ph-positive chronic myelogenous leukemia. Am J Hematol 35:110-113
10. Hermann C, Andersen E, Videbaek A (1980) Acute myeloblastic leukaemia in sarcoidosis treated with methotrexate. Scand J Haematol 24:234-236
11. Hilario R, Padre-Mendoza T, Albala MM (1980) Chronic granulocytic leukemia and carcinoma of the cervix in situ following renal transplantation. Am J Med Sci 280:115-118
12. Inokuchi K, Futaki M, Hanawa H, Tanosaki S, Yamaguchi H, Iwakiri R, Nomura T, Dan K (1997) Heterogeneous expression of bcr-abl fusion mRNA in a patient with Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Br J Haematol 97:837-840
13. Khojasteh A, Perry MC, Taylor HM (1981) Chronic myelocytic leukemia developing as a second cancer in a patient with chronic lymphocytic leukemia. CA Cancer J Clin 31:172-176
14. Kirk JA, Radich J, Edmands S, Lee A, VanDevanter DR, Reems JA, Bryant EM (1996) Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia. Am J Hematol 52:129-134
15. Lemes A, Gomez Casares MT, de la Iglesia S, Matutes E, Molero MT (1999) p190 BCR-ABL rearrangement in chronic myeloid leukemia and acute lymphoblastic leukemia. Cancer Genet Cytogenet 113:100-102
16. Lubynski R, Meyers AM, Disler PB, MacPhail AP, Myburgh JA, Katz J (1978) Chronic granulocytic leukemia in a patient with a renal allograft. Arch Intern Med 138:1429-1430
17. Lugo TG, Pendergast AM, Muller AJ, Witte ON (1999) Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247:1079-1082
18. Melo JV, Myint H, Galton DA, Goldman JM (1994) P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia? Leukemia 8:208-211
19. Mooy JM, Hagenouw-Taal JC, Lameijer LD, van Turnhout JM (1978) Chronic granulocytic leukemia in a renal transplant recipient. Cancer 41:7-9
20. Myint H, Ross FM, Hall JL, Hamblin TJ (1997) Early transformation to acute myeloblastic leukaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia. Leuk Res 21:473-474
21. Nakamura Y, Hirosawa S, Aoki N (1993) Consistent involvement of the 3′ half part of the first BCR intron in adult Philadelphia-positive leukaemia without M-bcr rearrangement. Br J Haematol 83:53-57
22. Ohno T, Hada S, Sugiyama T, Mizumoto T, Furukawa H, Nagai K (1998) Chronic myeloid leukemia with minor-bcr breakpoint developed hybrid type of blast crisis. Am J Hematol 57:320-325
23. Pawson T (1988) Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene 3:491-495
24. Pedersen-Bjergaard J, Brondum-Nielsen K, Karle H, Johansson B (1997) Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? Leukemia 11:1571-1574
25. Pendergast AM, Muller AJ, Havlik MH, Maru Y, Witte ON (1991) BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner. Cell 66:161-171
26. Reiter A, Skladny H, Hochhaus A, Seifarth W, Heimpel H, Bartram CR, Cross NC, Hehlmann R (1997) Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis. Br J Haematol 97:86-93
27. Rosner F, Carey RW, Zarrabi MH (1978) Breast cancer and acute leukemia: report of 24 cases and review of the literature. Am J Hematol 4:151-172
28. Sawyers CL, Timson L, Kawasaki ES, Clark SS, Witte ON, Champlin R (1990) Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc Natl Acad Sci U S A 87:563-567
29. Schreiber ZA, Axelrod MR, Abebe LS (1984) Coexistence of chronic myelogenous leukemia and chronic lymphocytic leukemia. Cancer 54:697-701
30. Selleri L, von Lindern M, Hermans A, Meijer D, Torelli G, Grosveld G (1990) Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript. Blood 75:1146-1153
31. Stahl ML, Ferenz CR, Kelleher KL, Kriz RW, Knopf JL (1988) Sequence similarity of phospholipase C with the non-catalytic region of src. Nature 332:269-272
32. Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD (1993) Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705-3711
33. Takahashi N, Miura I, Saitoh K, Miura AB (1998) Lineage involvement of stem cells bearing the Philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization. Blood 92:4758-4763
34. Teichmann JV, Sieber G, Ludwig WD, Karow J, Ruehl H (1986) Chronic myelocytic leukemia as a second neoplasia in the course of chronic lymphocytic leukemia. Case report and review of the literature. Leuk Res 10:361-368
35. Verhoef GE, Demuynck H, Stul MS, Cassiman JJ, Mecucci C, Van Den Berghe H, Boogaerts MA (1990) Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease. Cancer Genet Cytogenet 49:171-176
36. Waller CF, Fetscher S, Lange W (1999) Treatment-related chronic myelogenous leukemia. Ann Hematol 78:341-354
37. Wanders J, Wattendolff AR, Endtz LJ, den Nijs JJ, Leeksma CHW (1981) Chronic myeloid leukemia in myasthenia gravis after long term treatment with 6-mercaptopurine. Acta Med Scand 210:235-238
38. Whang-Peng J, Young RC, Lee EC, Longo DL, Schechter GP, DeVita VT (1988) Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after treatment modalities. Blood 71:403-414
39. Yamaguchi H, Inokuchi K, Shinohara T, Dan K (1998) Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts. Cancer Genet Cytogenet 102:74-77
40. Zaccaria A, Tassinari A, Testoni N, Lauria F, Tura S, Algeri R, Guerrasio A, Rosso C, Saglio G (1990) Alternative BCR/ABL transcripts in chronic myeloid leukemia. Blood 76:1663-1665